BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17553488)

  • 21. Overexpression of PKD1 causes polycystic kidney disease.
    Thivierge C; Kurbegovic A; Couillard M; Guillaume R; Coté O; Trudel M
    Mol Cell Biol; 2006 Feb; 26(4):1538-48. PubMed ID: 16449663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Autosomal dominant polycystic kidney disease: modification of disease progression.
    Peters DJ; Breuning MH
    Lancet; 2001 Oct; 358(9291):1439-44. PubMed ID: 11705510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A truncated polycystin-2 protein causes polycystic kidney disease and retinal degeneration in transgenic rats.
    Gallagher AR; Hoffmann S; Brown N; Cedzich A; Meruvu S; Podlich D; Feng Y; Könecke V; de Vries U; Hammes HP; Gretz N; Witzgall R
    J Am Soc Nephrol; 2006 Oct; 17(10):2719-30. PubMed ID: 16943309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PKDB: Polycystic Kidney Disease Mutation Database--a gene variant database for autosomal dominant polycystic kidney disease.
    Gout AM; Martin NC; Brown AF; Ravine D
    Hum Mutat; 2007 Jul; 28(7):654-9. PubMed ID: 17370309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic kidney disease and renal lymphoma in a cat.
    Podell M; DiBartola SP; Rosol TJ
    J Am Vet Med Assoc; 1992 Sep; 201(6):906-9. PubMed ID: 1399804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gross genomic rearrangement involving the TSC2-PKD1 contiguous deletion syndrome: characterization of the deletion event by quantitative polymerase chain reaction deletion assay.
    Boehm D; Bacher J; Neumann HP
    Am J Kidney Dis; 2007 Jan; 49(1):e11-21. PubMed ID: 17185137
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel human pathological mutations. Gene symbol: PKD1. Disease: human autosomal dominant polycystic kidney disease.
    Li L
    Hum Genet; 2007 Nov; 122(3-4):413-4. PubMed ID: 18350644
    [No Abstract]   [Full Text] [Related]  

  • 29. Polycystic kidney disease in a Neva Masquerade cat.
    Jasik A; Kulesza M
    J Small Anim Pract; 2014 Jul; 55(7):387. PubMed ID: 24905486
    [No Abstract]   [Full Text] [Related]  

  • 30. Polycystic kidney disease in a family of Persian cats.
    Biller DS; Chew DJ; DiBartola SP
    J Am Vet Med Assoc; 1990 Apr; 196(8):1288-90. PubMed ID: 2185204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetic diagnosis of autosomal dominant polycystic kidney disease using multiplex-PCR].
    Buset Ríos N; Rodríguez Pérez JC; Sánchez JJ; Hernández CR; Hernández E; Torres Galván MJ
    Nefrologia; 2009; 29(4):327-30. PubMed ID: 19668304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A length polymorphism in an intron of the canine polycystic kidney disease 1 gene.
    Liu PC; Chen YW; Shibuya H; Lubahn DB; Johnson GS
    Anim Genet; 1998 Aug; 29(4):322-3. PubMed ID: 9745674
    [No Abstract]   [Full Text] [Related]  

  • 33. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
    Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
    Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.
    Happé H; Leonhard WN; van der Wal A; van de Water B; Lantinga-van Leeuwen IS; Breuning MH; de Heer E; Peters DJ
    Hum Mol Genet; 2009 Jul; 18(14):2532-42. PubMed ID: 19401297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of the polycystic kidney disease and renal and urinary bladder ultrasonographic abnormalities in Persian and Exotic Shorthair cats in Italy.
    Bonazzi M; Volta A; Gnudi G; Bottarelli E; Gazzola M; Bertoni G
    J Feline Med Surg; 2007 Oct; 9(5):387-91. PubMed ID: 17498994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease.
    Tan YC; Blumenfeld JD; Anghel R; Donahue S; Belenkaya R; Balina M; Parker T; Levine D; Leonard DG; Rennert H
    Hum Mutat; 2009 Feb; 30(2):264-73. PubMed ID: 18837007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic kidney disease in a Chartreux cat.
    Volta A; Manfredi S; Gnudi G; Gelati A; Bertoni G
    J Feline Med Surg; 2010 Feb; 12(2):138-40. PubMed ID: 19716738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of polycystic kidney disease in Persian and Persian related cats in France.
    Barthez PY; Rivier P; Begon D
    J Feline Med Surg; 2003 Dec; 5(6):345-7. PubMed ID: 14623204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Polycystic kidney diseases: molecular genetics and counselling].
    Lespinasse J; Fourcade J; Schir F
    Nephrol Ther; 2006 Jul; 2(3):120-6. PubMed ID: 16890136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autosomal dominant polycystic kidney disease in Persian and Persian-cross cats.
    Eaton KA; Biller DS; DiBartola SP; Radin MJ; Wellman ML
    Vet Pathol; 1997 Mar; 34(2):117-26. PubMed ID: 9066078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.